Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare ConferenceBusiness Wire • 08/29/24
Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/08/24
Analysts Estimate Quanterix Corporation (QTRX) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 07/29/24
Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimer's Disease Detection that is More Effective than Standalone Plasma p-Tau 217Business Wire • 07/29/24
Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare ConferenceBusiness Wire • 06/05/24
Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024Business Wire • 05/22/24
Wall Street Analysts Believe Quanterix (QTRX) Could Rally 67.66%: Here's is How to TradeZacks Investment Research • 05/15/24
Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/07/24
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing InfrastructureBusiness Wire • 03/21/24
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer's DiseaseBusiness Wire • 03/04/24
Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 02/29/24
Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 GuidanceBusiness Wire • 02/26/24